Provided by Tiger Trade Technology Pte. Ltd.

Monkeypox Concept

2,087.92
-5.5945-0.27%
Number of Gainers:5
Number of Losers:5
Number of Flat:1
PE:- -
High:2,106.99
Open:2,082.10
Low:2,072.66
Close:2,093.51
Volume:19.89M
Turnover:1.12B
Market Cap:231.04B
Float Cap:230.32B

Loading ...

Virax Biolabs Adjourns Shareholder Meeting After Quorum Fails to Show

Reuters
·
1 hour ago

Gilead Sciences Updates Financial Calendar with Investor Conference Presentations

Reuters
·
2 hours ago

3 Defensive Dividend Stocks for Investors Seeking Shelter From Market Volatility

Simply Wall St.
·
Yesterday

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Yesterday

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
Yesterday

Quest Diagnostics Teams with Humanity to Offer Biological Age Analysis on Questhealth.com

Reuters
·
Aug 25

Quest Diagnostics CEO Jim Davis to Speak at Baird Global Healthcare Conference

Reuters
·
Aug 25

August 2026's Highlighted Stocks That May Be Trading Below Estimated Value

Simply Wall St.
·
Aug 25

Quest Diagnostics CFO Sam Samad to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Aug 24

Quest Diagnostics to Add Roche's Elecsys to Alzheimer's Biomarker Test Portfolio

MT Newswires Live
·
Aug 24

Tonix Pharma Director Richard H. Bagger Acquires Common Shares Worth $12,600

Reuters
·
Aug 24

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 24

Quest Diagnostics - to Launch New Ad-Detect Multi-Biomarker Lab Test Nationwide at Month-End

THOMSON REUTERS
·
Aug 24

Quest Diagnostics - to Incorporate Roche Ptau217 Test in Ad-Detect Panels in 2027

THOMSON REUTERS
·
Aug 24

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Reuters
·
Aug 24

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS
·
Aug 24

Funds: What a Top Biotech Fund is Buying Now

Dow Jones
·
Aug 22

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Reuters
·
Aug 22

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 22